Purple Biotech is a clinical stage biopharmaceutical company developing therapeutic candidates, including oncology treatments. PPBT reports earnings on Fri, Nov 13, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 7 | HC Wainwright & Co. | Maintained | Buy |
Seasonality
How PPBT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
Whale Options Flow
90DNo whale options trades in PPBT in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PPBT is in one of them and how their past PPBT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered PPBT in an article yet. Here's the latest on the wider market.
About Purple Biotech
Purple Biotech is a clinical stage biopharmaceutical company based in Rehovot, Israel. It develops therapeutic candidates, including candidates for oncology, with the aim of obtaining regulatory approval and selling them to patients and the healthcare market. The company has not yet commercialized a product on its own and relies on outside parties for manufacturing, clinical trials and possible commercialization partnerships.
- Headquarters
- Rehovot, Israel
- Founded
- 1968